Ultrasis plc Appoints Capital to Boost Financial Communications

Ultrasis plc, the provider of computer-delivered, interactive healthcare products and associated services, has appointed Capital MS&L to lead its financial PR and investor relations.

The AIM-listed company wants to ensure investors, analysts, commentators and the healthcare sector are informed about its progress in delivering computerised cognitive behavioural therapy (CBT) programmes for the treatment of depression, stress and anxiety.

Using its expertise in health, psychology, software development and programme management, the Company is targeting its computerised healthcare products at the NHS, the corporate sector and other healthcare providers in the UK and US.

Ultrasis won key endorsement in February 2006 when the National Institute for Health and Clinical Excellence (NICE) recommended its Beating the Blues product, developed in collaboration with Dr Judy Proudfoot and her colleagues at the Institute of Psychiatry, London, as a treatment option for people with mild or moderate depression.

As the first to offer computerised products based on CBT and interactive multimedia, Ultrasis remains the world leader in this field. The Company’s portfolio of clinically valid products helps people tackle stress, anxiety, depression and related chronic conditions.

Beating the Blues, in particular, is expected to have a major impact on the ability of GPs to offer non-pharmaceutical treatments and reduce waiting lists for cognitive behavioural therapy. CBT has been shown to be a cost effective and time-efficient way of helping people suffering from anxiety and depression to get better and stay better.

Commenting on the appointment of Capital, Nigel Brabbins, Chief Executive of Ultrasis plc, said: “The NICE endorsement of our first product was a major landmark for us, but this sort of recognition is the result of a sustained effort by our team. Now more than previously, we need to make certain our stakeholders and customers understand our offering.”

Peter Curtain, the Capital director leading the account, said: “We are delighted by this vote of confidence by the Ultrasis Board and look forward to working with this terrific Company.”

Media enquiries:

Notes to editors:

Ultrasis is a healthcare company with core expertise in health, psychology, software development and programme management. The Company delivers computerised healthcare products to the NHS, the corporate sector and other healthcare providers in the UK and US.

Ultrasis was the first company to offer computerised products based on Cognitive Behavioural Therapy (CBT) and interactive multimedia, and is the world leader in this field. The products help people tackle stress, anxiety and depression, and a full spectrum of related chronic conditions.

###